采用英国儿童癌症协作组（UKCCSG）方案治疗的非霍奇金淋巴瘤和T细胞白血病患儿的第二原发恶性肿瘤
Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens.
作者信息
Ingram L, Mott M G, Mann J R, Raafat F, Darbyshire P J, Morris Jones P H
出版信息
Br J Cancer. 1987 Apr;55(4):463-6. doi: 10.1038/bjc.1987.91.
Abstract
Eight children treated between 1977 and 1983 with the UK Children's Cancer Study Group's non-Hodgkin lymphoma (NHL) and T-cell protocols have developed second malignancies within 7 years of commencing treatment. Five developed acute non-lymphoblastic leukaemia and a sixth died from infection while pancytopenic with a pre-leukaemic marrow. The other malignancies were cerebral astrocytoma and an undifferentiated low grade sarcoma. These eight children were included among 261 children studied in the first UKCCSG NHL and T-cell trials giving an actuarial incidence of 7.8% second malignancy at 7 years. Six had received adjuvant radiotherapy which may have contributed to the high incidence of second malignancy.
摘要
1977年至1983年间，按照英国儿童癌症研究组的非霍奇金淋巴瘤（NHL）和T细胞方案接受治疗的8名儿童在开始治疗后的7年内发生了第二种恶性肿瘤。5名儿童患上了急性非淋巴细胞白血病，第6名儿童在全血细胞减少且骨髓呈白血病前期时死于感染。其他恶性肿瘤为脑星形细胞瘤和未分化的低级别肉瘤。在英国儿童癌症研究组的首次NHL和T细胞试验研究的261名儿童中包括了这8名儿童，7年时第二种恶性肿瘤的精算发病率为7.8%。其中6名儿童接受了辅助放疗，这可能是导致第二种恶性肿瘤高发病率的原因。
相似文献
1
Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens.采用英国儿童癌症协作组（UKCCSG）方案治疗的非霍奇金淋巴瘤和T细胞白血病患儿的第二原发恶性肿瘤
Br J Cancer. 1987 Apr;55(4):463-6. doi: 10.1038/bjc.1987.91.
2
Risk of leukemia following treatment for non-Hodgkin's lymphoma.非霍奇金淋巴瘤治疗后发生白血病的风险。
J Natl Cancer Inst. 1994 Oct 5;86(19):1450-7. doi: 10.1093/jnci/86.19.1450.
3
Second malignancies following treatment in non-Hodgkin's lymphoma.非霍奇金淋巴瘤治疗后的第二原发恶性肿瘤。
Leuk Lymphoma. 1993 Mar;9(4-5):337-42. doi: 10.3109/10428199309148531.
4
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).与接受环磷酰胺、卡莫司汀和依托泊苷（CBV）方案自体移植的霍奇金病患者相比，非霍奇金淋巴瘤患者移植后骨髓增生异常综合征/急性白血病的发病率。
Leuk Lymphoma. 2001 Feb;40(5-6):499-509. doi: 10.3109/10428190109097649.
5
Pneumonia diagnosis in childhood and incidence of leukaemia, lymphoma and brain cancer: a Danish nationwide cohort study.儿童肺炎诊断与白血病、淋巴瘤和脑癌发病率：一项丹麦全国性队列研究。
BMJ Open. 2017 Dec 29;7(12):e019860. doi: 10.1136/bmjopen-2017-019860.
6
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.儿童和青年早期非霍奇金淋巴瘤的治疗
N Engl J Med. 1997 Oct 30;337(18):1259-66. doi: 10.1056/NEJM199710303371802.
7
The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.最大支持性治疗对剂量依从性和生存的影响。1984年至1993年期间治疗的儿童急性淋巴细胞白血病和非霍奇金淋巴瘤的单中心分析。
Klin Padiatr. 1997 Jul-Aug;209(4):235-42. doi: 10.1055/s-2008-1043956.
8
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.对于接受过先前剂量限制性放射治疗的淋巴恶性肿瘤患者，给予大剂量环磷酰胺、卡莫司汀和依托泊苷，随后进行异基因骨髓移植。
J Clin Oncol. 1995 Mar;13(3):596-602. doi: 10.1200/JCO.1995.13.3.596.
9
10
Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.儿童霍奇金病后继发的第二原发性恶性肿瘤：治疗及脾切除术作为危险因素
Med Pediatr Oncol. 1989;17(6):477-84.
引用本文的文献
1
Therapy Related AML/MDS Following Treatment for Childhood Cancer: Experience from a Tertiary Care Centre in North India.儿童癌症治疗后与治疗相关的急性髓系白血病/骨髓增生异常综合征：来自印度北部一家三级医疗中心的经验。
Indian J Hematol Blood Transfus. 2018 Jan;34(1):78-82. doi: 10.1007/s12288-017-0840-x. Epub 2017 Jun 19.
2
What's all the fuss about? facts and figures about bone marrow failure and conditions.有什么大惊小怪的？骨髓衰竭和相关病症的事实与数据。
Curr Hematol Malig Rep. 2012 Dec;7(4):300-9. doi: 10.1007/s11899-012-0134-1.
3
Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.老年非霍奇金淋巴瘤患者使用白细胞生长因子与急性髓系白血病或骨髓增生异常综合征风险。
Cancer. 2010 Nov 15;116(22):5279-89. doi: 10.1002/cncr.25525.
4
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.非霍奇金淋巴瘤后的特定病因死亡率和二次癌症发病率：来自儿童癌症幸存者研究的报告
Blood. 2008 Apr 15;111(8):4014-21. doi: 10.1182/blood-2007-08-106021. Epub 2008 Feb 7.
5
Patterns of multiple primary tumours in patients treated for cancer during childhood.儿童期癌症患者的多原发性肿瘤模式
Br J Cancer. 1987 Sep;56(3):331-8. doi: 10.1038/bjc.1987.199.
6
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.表鬼臼毒素、烷化剂、放疗与儿童癌症后继发白血病的风险
BMJ. 1992 Apr 11;304(6832):951-8. doi: 10.1136/bmj.304.6832.951.
7
Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985.1974年至1985年间被诊断为非霍奇金淋巴瘤的儿童的死因。
Arch Dis Child. 1992 Nov;67(11):1378-83. doi: 10.1136/adc.67.11.1378.
8
Avoiding chemotherapy related late effects in children with curable tumours.避免可治愈肿瘤患儿出现化疗相关的远期效应。
Arch Dis Child. 1992 Sep;67(9):1116-9. doi: 10.1136/adc.67.9.1116.
本文引用的文献
1
Second malignancies in non-Hodgkin's lymphoma.非霍奇金淋巴瘤中的第二原发性恶性肿瘤
Cancer. 1981 Sep 15;48(6):1299-301. doi: 10.1002/1097-0142(19810915)48:6<1299::aid-cncr2820480608>3.0.co;2-2.
2
Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.霍奇金淋巴瘤治疗后长达10年的急性非淋巴细胞白血病、白血病前期及急性骨髓增殖综合征的发病率
N Engl J Med. 1982 Oct 14;307(16):965-71. doi: 10.1056/NEJM198210143071601.
3
A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma.儿童非霍奇金淋巴瘤综合治疗的随机试验。
Cancer. 1980 Feb 15;45(4):630-7. doi: 10.1002/1097-0142(19800215)45:4<630::aid-cncr2820450403>3.0.co;2-5.
4
Acute myeloid leukemia following treatment of Hodgkin's disease: a review.霍奇金病治疗后发生的急性髓系白血病：综述
Cancer. 1982 Aug 15;50(4):676-83. doi: 10.1002/1097-0142(19820815)50:4<676::aid-cncr2820500410>3.0.co;2-b.
5
Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.急性非淋巴细胞白血病、白血病前期以及继发于其他恶性疾病治疗后的急性骨髓增殖综合征。II. 55例患者的骨髓细胞学、细胞遗传学、HLA分型结果、抗白血病化疗反应及生存情况
Cancer. 1984 Aug 1;54(3):452-62. doi: 10.1002/1097-0142(19840801)54:3<452::aid-cncr2820540313>3.0.co;2-9.
6
Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).儿童非霍奇金淋巴瘤的辅助低剂量放疗（来自英国儿童癌症研究组——UKCCSG的报告）
Br J Cancer. 1984 Oct;50(4):463-9. doi: 10.1038/bjc.1984.202.
7
Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).儿童T细胞白血病/淋巴瘤的辅助低剂量放疗（来自英国儿童癌症研究组——UKCCSG的报告）
Br J Cancer. 1984 Oct;50(4):457-62. doi: 10.1038/bjc.1984.201.
8
Incidence of second malignant neoplasms in children: results of an international study.儿童继发性恶性肿瘤的发病率：一项国际研究的结果
Lancet. 1982 Dec 11;2(8311):1326-31. doi: 10.1016/s0140-6736(82)91524-0.
9
Chromosomal breakage and acute leukemia in congenital telangiectatic erythema and stunted growth.先天性毛细血管扩张性红斑及生长发育迟缓中的染色体断裂与急性白血病。
Ann Intern Med. 1966 Sep;65(3):487-95. doi: 10.7326/0003-4819-65-3-487.
10
Serial incidence of bone marrow GM-CFC prior to the development of acute non-lymphoblastic leukaemia in a child treated for non-Hodgkin's lymphoma.一名接受非霍奇金淋巴瘤治疗的儿童在发生急性非淋巴细胞白血病之前骨髓粒-巨噬细胞集落形成细胞（GM-CFC）的连续发生率。
Br J Haematol. 1985 Jan;59(1):79-84. doi: 10.1111/j.1365-2141.1985.tb02966.x.
Zotero 插件